Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS: PBSV · Delayed Price · USD
0.735
+0.035 (5.00%)
Apr 25, 2024, 1:28 PM EDT - Market open
Pharma-Bio Serv Income Statement
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.98 | 19.4 | 20.12 | 21.56 | 19.51 | 17.8 | 15.58 | 19.54 | 23.38 | 27.56 | Upgrade
|
| Revenue Growth (YoY) | -12.48% | -3.56% | -6.72% | 10.55% | 9.61% | 14.24% | -20.26% | -16.46% | -15.13% | -16.66% | Upgrade
|
| Cost of Revenue | 11.91 | 14.52 | 14.76 | 14.9 | 13.33 | 12.11 | 11.97 | 13.75 | 15.9 | 18.58 | Upgrade
|
| Gross Profit | 5.07 | 4.88 | 5.36 | 6.67 | 6.18 | 5.69 | 3.61 | 5.78 | 7.48 | 8.97 | Upgrade
|
| Selling, General & Admin | 3.95 | 3.71 | 9.21 | 4.44 | 4.48 | 4.6 | 5.04 | 5.87 | 5.7 | 6.11 | Upgrade
|
| Other Operating Expenses | 0.57 | 0.01 | 1.98 | 0.06 | 0.53 | 0.44 | 0 | 0 | 0 | 0 | Upgrade
|
| Operating Expenses | 3.95 | 3.71 | 9.21 | 4.44 | 4.48 | 4.6 | 5.04 | 5.87 | 5.7 | 6.11 | Upgrade
|
| Operating Income | 1.12 | 1.17 | -3.85 | 2.23 | 1.7 | 1.09 | -1.43 | -0.09 | 1.78 | 2.86 | Upgrade
|
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.01 | Upgrade
|
| Interest Expense | 0 | -0.01 | 0 | 0 | 0 | -2.98 | -0.03 | 0.22 | 0.01 | 0.01 | Upgrade
|
| Other Expense / Income | -0.57 | - | -1.98 | -0.06 | -0.53 | - | 0.01 | -0.11 | - | -0.02 | Upgrade
|
| Pretax Income | 1.69 | 1.19 | -1.88 | 2.29 | 2.22 | 1.52 | -1.41 | -0.2 | 1.79 | 2.88 | Upgrade
|
| Income Tax | 0.38 | 0.18 | 0.21 | 0.24 | 0.14 | 2.79 | 0 | 0.05 | 0.17 | 0.46 | Upgrade
|
| Net Income | 1.31 | 1.01 | -2.09 | 2.05 | 2.09 | 1.28 | -1.41 | -0.26 | 1.62 | 2.41 | Upgrade
|
| Net Income Growth | 30.15% | - | - | -1.74% | 63.10% | - | - | - | -32.68% | -50.81% | Upgrade
|
| Shares Outstanding (Basic) | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 24 | Upgrade
|
| Shares Change | -0.15% | 0.02% | -0.06% | -0.32% | 0.08% | -0.01% | -0.37% | -0.92% | -1.24% | 0.14% | Upgrade
|
| EPS (Basic) | 0.06 | 0.04 | -0.09 | 0.09 | 0.09 | 0.06 | -0.06 | -0.01 | 0.07 | 0.11 | Upgrade
|
| EPS (Diluted) | 0.06 | 0.04 | -0.09 | 0.09 | 0.09 | 0.06 | -0.06 | -0.01 | 0.07 | 0.10 | Upgrade
|
| EPS Growth | 30.43% | - | - | -1.44% | 63.00% | - | - | - | -30.60% | -52.38% | Upgrade
|
| Free Cash Flow | 1.88 | 0.57 | 0.79 | 1.47 | -2.27 | 3.6 | -2 | -1.1 | 0.03 | 3.12 | Upgrade
|
| Free Cash Flow Per Share | 0.08 | 0.02 | 0.03 | 0.06 | -0.10 | 0.16 | -0.09 | -0.05 | 0.00 | 0.13 | Upgrade
|
| Gross Margin | 29.84% | 25.16% | 26.65% | 30.92% | 31.66% | 31.95% | 23.18% | 29.60% | 32.01% | 32.56% | Upgrade
|
| Operating Margin | 6.58% | 6.06% | -19.16% | 10.32% | 8.70% | 6.11% | -9.15% | -0.47% | 7.62% | 10.39% | Upgrade
|
| Profit Margin | 7.72% | 5.19% | -10.39% | 9.51% | 10.70% | 7.19% | -9.08% | -1.31% | 6.95% | 8.76% | Upgrade
|
| Free Cash Flow Margin | 11.10% | 2.95% | 3.95% | 6.82% | -11.61% | 20.21% | -12.84% | -5.63% | 0.13% | 11.33% | Upgrade
|
| Effective Tax Rate | 22.36% | 15.29% | - | 10.44% | 6.12% | 182.80% | - | - | 9.37% | 16.14% | Upgrade
|
| EBITDA | 1.31 | 1.23 | -3.78 | 2.31 | 1.8 | 1.16 | -1 | 0.33 | 2.16 | 3.25 | Upgrade
|
| EBITDA Margin | 7.73% | 6.32% | -18.80% | 10.72% | 9.21% | 6.53% | -6.39% | 1.70% | 9.23% | 11.78% | Upgrade
|
| Depreciation & Amortization | 0.19 | 0.05 | 0.07 | 0.09 | 0.1 | 0.07 | 0.44 | 0.31 | 0.36 | 0.38 | Upgrade
|
| EBIT | 1.12 | 1.17 | -3.85 | 2.23 | 1.7 | 1.09 | -1.44 | 0.02 | 1.8 | 2.87 | Upgrade
|
| EBIT Margin | 6.58% | 6.06% | -19.16% | 10.32% | 8.70% | 6.11% | -9.24% | 0.10% | 7.70% | 10.41% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.